Skip to content

Author

Wei-Wei Xu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Comparison of bortezomib with dexamethasone and thalidomide with dexamethasone in the treatment of patients with monoclonal immunoglobulin deposition disease.

Bortezomib/dexamethasone followed by autologous stem cell transplantation is recommended for transplant-eligible patients, while bortezomib/dexamethasone alone remains effective for those who are ineligible, which supports bortezomib/dexamethasone as first-line therapy.

Jianan Jiang, Wen-Cui Chen, Xiaomei Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.